Lifecore Biomedical, Inc. (LFCR)

NASDAQ: LFCR · Real-Time Price · USD

4.720

-0.010 (-0.21%)

At close: Aug 14, 2026, 4:00 PM EDT

4.650

-0.070 (-1.48%)

After-hours: Aug 14, 2026, 7:20 PM EDT

Lifecore Biomedical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022
Revenue	129.46	128.87	128.26	103.27	111.27
Revenue Growth	0.46%	0.47%	24.20%	-7.19%	10.31%
Cost of Revenue	88.85	88.57	86.41	75.28	72.2
Gross Profit	40.61	40.3	41.85	27.99	39.07
Selling, General & Admin	33.35	44.05	38.76	38.97	34.66
Research & Development	8.51	8.26	8.58	8.74	7.84
Operating Expenses	41.87	52.3	47.34	47.71	42.5
Operating Income	-1.26	-12.01	-5.49	-19.72	-3.43
Interest Expense	-27.17	-22.17	-18.15	-17.58	-15.47
Interest & Investment Income	0.47	0.33	0.06	-	-
Other Non Operating Income (Expenses)	-2.26	0.41	36.45	-0.81	6.57
EBT Excluding Unusual Items	-30.21	-33.44	12.87	-38.11	-12.33
Merger & Restructuring Charges	-	1.75	-1.66	-4.18	-8.36
Gain (Loss) on Sale of Assets	-	-6.99	-	2.11	-
Other Unusual Items	-	-	-1.7	-23.74	-
Pretax Income	-30.21	-38.67	9.51	-63.93	-20.69
Income Tax Expense	0.58	0.04	0.18	0.31	-5.21
Earnings From Continuing Operations	-30.79	-38.72	9.33	-64.24	-15.48
Earnings From Discontinued Operations	-	-	2.68	-35.33	-101.24
Net Income to Company	-30.79	-38.72	12.01	-99.56	-116.72
Net Income	-30.79	-38.72	12.01	-99.56	-116.72
Preferred Dividends & Other Adjustments	3.71	5.64	-	-	-
Net Income to Common	-34.5	-44.36	12.01	-99.56	-116.72
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	37	35	30	30	29
Shares Outstanding (Diluted)	37	35	37	30	29
Shares Change	7.33%	-5.02%	22.36%	1.67%	0.59%
EPS (Basic)	-0.92	-1.27	0.39	-3.32	-3.96
EPS (Diluted)	-0.93	-1.27	0.33	-3.32	-3.97
EPS Growth	-	-	-	-	-
Free Cash Flow	6.23	-13.62	-18.14	-38.92	-52.53
Free Cash Flow Per Share	0.17	-0.39	-0.49	-1.30	-1.78
Gross Margin	31.37%	31.27%	32.63%	27.10%	35.11%
Operating Margin	-0.97%	-9.32%	-4.28%	-19.10%	-3.08%
Profit Margin	-26.65%	-34.42%	9.37%	-96.41%	-104.89%
Free Cash Flow Margin	4.81%	-10.57%	-14.14%	-37.69%	-47.21%
EBITDA	8.24	-3.98	2.47	-7.04	14.23
EBITDA Margin	6.37%	-3.09%	1.92%	-6.82%	12.79%
D&A For EBITDA	9.5	8.03	7.95	12.68	17.66
EBIT	-1.26	-12.01	-5.49	-19.72	-3.43
EBIT Margin	-0.97%	-9.32%	-4.28%	-19.10%	-3.08%
Effective Tax Rate	-	-	1.92%	-	-
Revenue as Reported	129.46	128.87	128.26	103.27	111.27
Advertising Expenses	-	-	-	0.01	0.01

SEC Filings: 10-K · 10-Q